Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Adaptive licensing will fail if HTA bodies don't get on board, says Dutch reimbursement committee

This article was originally published in Scrip

Executive Summary

The European Medicine's Agency's plans for adaptive licensing are doomed to fail if Europe's health technology appraisal authorities do not get on board, according to Dr Martin van der Graaff from the CVZ, the influential Dutch authority that gives advice on the products that health insurers should reimburse. However, these agencies are not yet an integral part of the discussions, he said.





Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts